Toggle Main Menu Toggle Search

Open Access padlockePrints

Grip Strength and Walking Pace and Cardiovascular Disease Risk Prediction in 406,834 UK Biobank Participants

Lookup NU author(s): Dr Claire WelshORCiD, Dr Carlos Celis Morales


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


ObjectiveTo investigate whether the addition of grip strength and/or self-reported walking pace to established cardiovascular disease (CVD) risk scores improves their predictive abilities.Patients and MethodsA total of 406,834 participants from the UK Biobank, with baseline measurements between March 13, 2006, and October 1, 2010, without CVD at baseline were included in this study. Associations of grip strength and walking pace with CVD outcomes were investigated using Cox models adjusting for classical risk factors (as included in established risk scores), and predictive utility was determined by changes in C-index and categorical net reclassification index.ResultsOver a median of 8.87 years of follow-up (interquartile range 3, 8.25-9.47 years), there were 7274 composite fatal/nonfatal events (on the basis of the American College of Cardiology/American Heart Association [ACC/AHA] outcome) and 1955 fatal events (on the basis of the Systematic Coronary Risk Evaluation [SCORE] risk score). Both grip strength and walking pace were inversely associated with CVD outcomes after adjusting for classical risk factors. Addition of grip strength (change in C-index: ACC/AHA, +0.0017; SCORE, +0.0047), usual walking pace (ACC/AHA, +0.0031; SCORE, +0.0130), and both combined (ACC/AHA, +0.0041; SCORE, +0.0148) improved the C-index and also improved the net reclassification index (grip, +0.55%; walking pace, +0.53%; combined, 1.12%).ConclusionThe present study has found that the addition of grip strength or usual walking pace to existing risk scores results in improved CVD risk prediction, with an additive effect when both are added. As both these measures are cheap and easy to administer, these tools could provide an important addition to CVD risk screening, although further external validation is required.

Publication metadata

Author(s): Welsh CE, Celis-Morales C, Ho FK, Brown R, Mackay DF, Lyall DM, Anderson JJ, Pell JP, Gill JMR, Sattar N, Welsh P, Gray S

Publication type: Article

Publication status: Published

Journal: Mayo Clinic Proceedings

Year: 2020

Volume: 95

Issue: 5

Pages: 879-888

Print publication date: 01/05/2020

Online publication date: 13/04/2020

Acceptance date: 13/04/2020

ISSN (print): 0025-6196

Publisher: Elsevier


DOI: 10.1016/j.mayocp.2020.03.019.

PubMed id: 32370845


Altmetrics provided by Altmetric